Cita APA

Ruiz , M., Vaklavas, C., Baird, R., BERMEJO, B., Moreno, I., & Oliveira, M. (2025). Camizestrant in Combination with Three Globally Approved CDK4/6 Inhibitors in Women with ER+, HER2- Advanced Breast Cancer: Results from SERENA-1.

Citación estilo Chicago

Ruiz , Manuel, Christos Vaklavas, Richard Baird, BEGOÑA BERMEJO, Irene Moreno, y Mafalda Oliveira. Camizestrant in Combination With Three Globally Approved CDK4/6 Inhibitors in Women With ER+, HER2- Advanced Breast Cancer: Results From SERENA-1. 2025.

Cita MLA

Ruiz , Manuel, et al. Camizestrant in Combination With Three Globally Approved CDK4/6 Inhibitors in Women With ER+, HER2- Advanced Breast Cancer: Results From SERENA-1. 2025.